Peter F Thall
researcher
Facts
11 properties- Instance of
- human
- Occupation
- biostatistician
- Educated at
- Florida State University (1971–1975)[3]
- Award received
- Fellow of the American Statistical Association[5]
- Doctoral advisor
- Robert Serfling[4]
- Doctoral student
- Andrew G Chapple, J. Kyle Wathen[8][9]
- Family name
- Category:Thall (surname)[10]
- Member of
- American Statistical Association (2015–present)[6]
🏷️ Also known as
en Peter F Thall
en Peter F. Thall
en Peter Thall
🔖 Identifiers · 10
- ISNI
- 0000000032159308
- ORCID iD
- 0000-0002-7293-529X
- VIAF cluster ID
- 75554709
- Library of Congress Authorities ID
- n94803506
- Google Knowledge Graph ID
- /g/113y2jy47
- Google Scholar author ID
- LpWRQJcAAAAJ
- J9U entity ID
- 987007437449305171
- MR Author ID
- 210032
- Mathematics Genealogy Project ID
- 1466
- Yale LUX ID
- person/688ce993-3687-4cbe-885f-e8be4483dc1b
🔗 Connections
Author of 8
A Bayesian Machine Learning Approach for Optimizing Dynamic Treatment Regimes,
Adaptive Enrichment Designs in Clinical Trials,
A Phase I–II Basket Trial Design to Optimize Dose-Schedule Regimes Based on Delayed Outcomes,
Bayesian Group Sequential Clinical Trial Design Using Total Toxicity Burden and Progression-Free Survival,
Bayesian group sequential enrichment designs based on adaptive regression of response and survival time on baseline biomarkers,
Bayesian treatment comparison using parametric mixture priors computed from elicited histograms,
Comparing Bayesian early stopping boundaries for phase <scp>II</scp> clinical trials,
Precision Bayesian phase I‐II dose‐finding based on utilities tailored to prognostic subgroups
← Authored by 8
A Bayesian Machine Learning Approach for Optimizing Dynamic Treatment Regimes,
Adaptive Enrichment Designs in Clinical Trials,
A Phase I–II Basket Trial Design to Optimize Dose-Schedule Regimes Based on Delayed Outcomes,
Bayesian Group Sequential Clinical Trial Design Using Total Toxicity Burden and Progression-Free Survival,
Bayesian group sequential enrichment designs based on adaptive regression of response and survival time on baseline biomarkers,
Bayesian treatment comparison using parametric mixture priors computed from elicited histograms,
Comparing Bayesian early stopping boundaries for phase <scp>II</scp> clinical trials,
Precision Bayesian phase I‐II dose‐finding based on utilities tailored to prognostic subgroups
Affiliated with 1
Press Enter · cited answer in seconds
0 sources
Summary
Peter F Thall worked as a biostatistician[1].
Body
Career and Affiliations
Doctoral students include Andrew G Chapple[8], a biostatistician[12] and J. Kyle Wathen[9], a biostatistician[13], specialised in clinical study design[14].
FAQs
What did Peter F Thall do for work?
Peter F Thall worked as biostatistician[1].
Where did Peter F Thall go to school?
Peter F Thall was educated at Florida State University[3].
What awards did Peter F Thall receive?
Honors received include Fellow of the American Statistical Association[5].